Literature DB >> 8440420

Interleukin 6 production by peripheral blood mononuclear cells in patients with chronic hepatitis B virus infection and primary biliary cirrhosis.

S Kakumu1, T Shinagawa, T Ishikawa, K Yoshioka, T Wakita, N Ida.   

Abstract

IL-6 production by peripheral blood mononuclear cells (PBMC) was studied in patients with chronic hepatitis B virus (HBV) infection and primary biliary cirrhosis (PBC) using the ELISA method. Spontaneous production of IL-6 was significantly increased in patients with HBeAg+ chronic hepatitis (CH). The cultures stimulated with lipopolysaccharide and lectin-free interleukin-2 (IL-2) showed enhanced IL-6 production both in controls and all patient groups compared with culture without any stimulation. IL-6 production in response to IL-2 was higher in patients with HBeAg+ CH and PBC than in controls. In PBMC with increased IL-6 production, monocyte function was increased in patients with HBeAg+ CH and PBC, while B cells from PBC showed elevated response to Staphylococcus aureus Cowan 1. IL-6 production in the presence of HBeAg was greater in anti-HBe+ patients than in HBeAg+ ones. These results suggest that IL-6 response is involved in the immune response in patients with chronic liver disease.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8440420     DOI: 10.1007/bf02774999

Source DB:  PubMed          Journal:  Gastroenterol Jpn        ISSN: 0435-1339


  28 in total

1.  Anti-hepatitis C antibodies in patients with chronic non-A, non-B hepatitis: relation to disease progression and effect of interferon alpha.

Authors:  K Yoshioka; S Kakumu; H Hayashi; T Shinagawa; T Wakita; T Ishikawa; Y Itoh; M Takayanagi
Journal:  Am J Gastroenterol       Date:  1991-10       Impact factor: 10.864

2.  Determination of e antigen and antibody to e by means of passive hemagglutination method.

Authors:  K Takahashi; M Fukuda; K Baba; M Imai; Y Miyakawa; M Mayumi
Journal:  J Immunol       Date:  1977-11       Impact factor: 5.422

3.  IL-6/IFN-beta-2 as a circulating hormone. Induction by cytokine administration in humans.

Authors:  D M Jablons; J J Mulé; J K McIntosh; P B Sehgal; L T May; C M Huang; S A Rosenberg; M T Lotze
Journal:  J Immunol       Date:  1989-03-01       Impact factor: 5.422

4.  Production of tumor necrosis factor, interleukin 1, and interferon-gamma by peripheral blood mononuclear cells from patients with primary biliary cirrhosis.

Authors:  S Kakumu; K Yoshioka; Y Tsutsumi; T Wakita; M Arao
Journal:  Clin Immunol Immunopathol       Date:  1990-07

Review 5.  Interleukin 2: a class of T cell growth factors.

Authors:  J Watson; D Mochizuki
Journal:  Immunol Rev       Date:  1980       Impact factor: 12.988

6.  Production of B cell-stimulating factors by B cells in patients with systemic lupus erythematosus.

Authors:  Y Tanaka; K Saito; F Shirakawa; T Ota; H Suzuki; S Eto; U Yamashita
Journal:  J Immunol       Date:  1988-11-01       Impact factor: 5.422

7.  Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin.

Authors:  T Hirano; K Yasukawa; H Harada; T Taga; Y Watanabe; T Matsuda; S Kashiwamura; K Nakajima; K Koyama; A Iwamatsu
Journal:  Nature       Date:  1986 Nov 6-12       Impact factor: 49.962

8.  Circulating activated B cells in primary biliary cirrhosis.

Authors:  S P James; E A Jones; J H Hoofnagle; W Strober
Journal:  J Clin Immunol       Date:  1985-07       Impact factor: 8.317

9.  Analysis of intrathyroidal cytokine production in thyroid autoimmune disease: thyroid follicular cells produce interleukin-1 alpha and interleukin-6.

Authors:  B Grubeck-Loebenstein; G Buchan; D Chantry; H Kassal; M Londei; K Pirich; K Barrett; M Turner; W Waldhausl; M Feldmann
Journal:  Clin Exp Immunol       Date:  1989-09       Impact factor: 4.330

10.  Establishment of strongly neutralizing monoclonal antibody to human interleukin-6 and its epitope analysis.

Authors:  N Ida; S Sakurai; T Hosaka; K Hosoi; T Kunitomo; T Shimazu; T Maruyama; Y Matsuura; M Kohase
Journal:  Biochem Biophys Res Commun       Date:  1989-12-15       Impact factor: 3.575

View more
  11 in total

Review 1.  Primary biliary cirrhosis. Connecting molecular biology to clinical medicine.

Authors:  S Reynoso-Paz; R L Coppel; Y Nakanuma; M E Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2000-04       Impact factor: 8.667

2.  Identification of liver cancer progenitors whose malignant progression depends on autocrine IL-6 signaling.

Authors:  Guobin He; Debanjan Dhar; Hayato Nakagawa; Joan Font-Burgada; Hisanobu Ogata; Yuhong Jiang; Shabnam Shalapour; Ekihiro Seki; Shawn E Yost; Kristen Jepsen; Kelly A Frazer; Olivier Harismendy; Maria Hatziapostolou; Dimitrios Iliopoulos; Atsushi Suetsugu; Robert M Hoffman; Ryosuke Tateishi; Kazuhiko Koike; Michael Karin
Journal:  Cell       Date:  2013-10-10       Impact factor: 41.582

3.  Interleukin-6 and its soluble receptor in patients with liver cirrhosis and hepatocellular carcinoma.

Authors:  Maurizio Soresi; Lydia Giannitrapani; Fabio D'Antona; Ada-Maria Florena; Emanuele La Spada; Angela Terranova; Melchiorre Cervello; Natale D'Alessandro; Giuseppe Montalto
Journal:  World J Gastroenterol       Date:  2006-04-28       Impact factor: 5.742

Review 4.  The coexistence of Sjögren's syndrome and primary biliary cirrhosis: a comprehensive review.

Authors:  Ying Sun; Weici Zhang; Baosen Li; Zhengsheng Zou; Carlo Selmi; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2015-06       Impact factor: 8.667

5.  Thiamethoxam induced hepatotoxicity and pro-carcinogenicity in rabbits via motivation of oxidative stress, inflammation, and anti-apoptotic pathway.

Authors:  Osama S El Okle; Omnia I El Euony; Asmaa F Khafaga; Mohamed A Lebda
Journal:  Environ Sci Pollut Res Int       Date:  2017-12-01       Impact factor: 4.223

6.  IL-6 induces hepatic inflammation and collagen synthesis in vivo.

Authors:  I Choi; H S Kang; Y Yang; K H Pyun
Journal:  Clin Exp Immunol       Date:  1994-03       Impact factor: 4.330

7.  Prognostic value of baseline interleukin 6 levels in liver decompensation and survival in HCC patients undergoing radioembolization.

Authors:  Osman Öcal; Juozas Kupčinskas; Egidijus Morkunas; Holger Amthauer; Kerstin Schütte; Peter Malfertheiner; Heinz Josef Klümpen; Christian Sengel; Julia Benckert; Ricarda Seidensticker; Bruno Sangro; Moritz Wildgruber; Maciej Pech; Peter Bartenstein; Jens Ricke; Max Seidensticker
Journal:  EJNMMI Res       Date:  2021-06-02       Impact factor: 3.138

8.  Interleukin-6 Genetic Variation and Susceptibility to Gastric Cancer in an Iranian Population

Authors:  Marzieh Attar; Maryam Mansoori; Majid Shahbazi
Journal:  Asian Pac J Cancer Prev       Date:  2017-11-26

Review 9.  Jak-Stat Signaling Induced by Interleukin-6 Family Cytokines in Hepatocellular Carcinoma.

Authors:  Juliane Lokau; Victor Schoeder; Johannes Haybaeck; Christoph Garbers
Journal:  Cancers (Basel)       Date:  2019-11-01       Impact factor: 6.639

10.  Baseline Interleukin-6 and -8 predict response and survival in patients with advanced hepatocellular carcinoma treated with sorafenib monotherapy: an exploratory post hoc analysis of the SORAMIC trial.

Authors:  Osman Öcal; Kerstin Schütte; Juozas Kupčinskas; Egidijus Morkunas; Gabija Jurkeviciute; Enrico N de Toni; Najib Ben Khaled; Thomas Berg; Peter Malfertheiner; Heinz Josef Klümpen; Christian Sengel; Bristi Basu; Juan W Valle; Julia Benckert; Antonio Gasbarrini; Daniel Palmer; Ricarda Seidensticker; Moritz Wildgruber; Bruno Sangro; Maciej Pech; Jens Ricke; Max Seidensticker
Journal:  J Cancer Res Clin Oncol       Date:  2021-04-14       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.